BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15881721)

  • 1. [Gaucher's disease. Substitutive enzymatic treatment in one case and a review of the literature].
    Rachid M; Harif M; Quessar A; Jabri L; Benchekroun S
    Tunis Med; 2005 Jan; 83(1):43-7. PubMed ID: 15881721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease: A 10 year old girl with anemia and huge spelenomegaly (a case report).
    Davarian A; Mirbehbahani NB
    Pak J Biol Sci; 2008 Apr; 11(7):1063-5. PubMed ID: 18810981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First long-term results of imiglucerase therapy of type 1 Gaucher disease.
    Niederau C; vom Dahl S; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up.
    Wang TJ; Chen MS; Shih YF; Hwu WL; Lai MY
    Am J Ophthalmol; 2005 Feb; 139(2):359-62. PubMed ID: 15734007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher's disease: the changing paradigm of a lysosomal disorder.
    Mehta A
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():3-5. PubMed ID: 22230118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
    Sherer Y; Dulitzki M; Levy Y; Livneh A; Shoenfeld Y; Langevitz P
    Ann Hematol; 2002 Mar; 81(3):161-3. PubMed ID: 11904743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of use of velaglucerase in 2 patients with type 1 Gaucher's disease].
    Latre P; Giraldo P
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():39-42. PubMed ID: 22230124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiglucerase and its use for the treatment of Gaucher's disease.
    Weinreb NJ
    Expert Opin Pharmacother; 2008 Aug; 9(11):1987-2000. PubMed ID: 18627336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
    Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
    An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Belmatoug N; Azorin M; Huten D; de Villemeur TB; Carbon C
    Rev Med Interne; 1993; 14(10):996. PubMed ID: 8009089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.